Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis.
about
Mucormycosis, pseudallescheriasis, and other uncommon mold infectionsA newly identified derivative of amphotericin B: isolation, structure determination and primary evaluation of the activity and toxicity.Recent advances in the treatment of mucormycosis.Stability in the cumulative incidence, severity and mortality of 101 cases of invasive mucormycosis in high-risk patients from 1995 to 2011: a comparison of eras immediately before and after the availability of voriconazole and echinocandin-amphoterComparative pharmacodynamics of posaconazole in neutropenic murine models of invasive pulmonary aspergillosis and mucormycosis.Antifungal pharmacokinetics and pharmacodynamicsIntranasal granulocyte-macrophage colony-stimulating factor reduces the Aspergillus burden in an immunosuppressed murine model of pulmonary aspergillosis.Invasive fungal infections in acute leukemia.Pharmacodynamics and dose-response relationships of liposomal amphotericin B against different azole-resistant Aspergillus fumigatus isolates in a murine model of disseminated aspergillosisEfficacy of single-dose liposomal amphotericin B or micafungin prophylaxis in a neutropenic murine model of invasive pulmonary aspergillosis.Pharmacokinetics and buccal mucosal concentrations of a 15 milligram per kilogram of body weight total dose of liposomal amphotericin B administered as a single dose (15 mg/kg), weekly dose (7.5 mg/kg), or daily dose (1 mg/kg) in peripheral stem celManaging fungal and viral infections in pediatric leukemia.Amphotericin B use in children: conventional and lipid-based formulations.Tissue pharmacokinetics and pharmacodynamics of AmBisome® (L-AmBis) in uninfected and infected animals and their effects on dosing regimens.Expression of Toll-like receptor 4 in lungs of immune-suppressed rat with Acinetobacter baumannii infectionAerosolized Delivery of Antifungal AgentsToxicity and efficacy differences between liposomal amphotericin B formulations in uninfected and Aspergillus fumigatus infected mice.Amphotericin B lipid complex: treatment of invasive fungal infections in patients refractory to or intolerant of amphotericin B deoxycholate.Comparative pharmacodynamics of amphotericin B lipid complex and liposomal amphotericin B in a murine model of pulmonary mucormycosis.High-dose induction liposomal amphotericin B followed by de-escalation is effective in experimental Aspergillus terreus pneumonia.
P2860
Q24603297-EA092D6E-4FE6-46F8-A0F0-FBA13E941BEFQ33626386-6A111E85-0BD9-4E20-80C4-D42B3AF5956CQ34161213-761171D4-D3B1-47B5-A5FD-C7D33C30BA0FQ34315804-8E85534E-0B76-4766-94D3-5EC16038D844Q34596761-5F18B72E-B8B9-453F-BE53-17AB06CC052CQ35663841-B898CFB1-F721-4C9B-B93D-FC4825981634Q36425073-A332277D-AFB9-48F1-86A7-F5E2D20800F2Q36612597-2212B39D-51AF-42F7-A29B-77E148C9FE2FQ36757621-48B04F3A-00BC-4CDD-B998-844BCC11140BQ36949553-784618CF-3E08-45A1-BA98-94102995C67AQ37333175-ADC1D3A2-A9D2-494F-A891-0EF13092E769Q37810281-A8CF926E-26A2-427F-8CD0-3ADF10182C35Q37854727-D2357FBA-6018-4127-A097-774887D52F27Q40222438-D1194048-85AC-43B6-A462-7DFB12F7088BQ40516975-4FDB0F59-DAB8-4D6E-9BE9-C4BDFD3E2713Q40522508-40FB874C-9680-44C4-9EC1-7FDC17C2178FQ41570433-22B5C67C-F467-48D8-8A21-C871D711F7A2Q41897364-D4D9F432-AF0B-4918-9AF2-8F54F1F02062Q42075610-2BE822E1-2B72-4B19-B948-7B2088FCD281Q42277564-FB233472-B021-4958-B0C5-A5E4C053D99E
P2860
Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Comparative analysis of amphot ...... asive pulmonary aspergillosis.
@ast
Comparative analysis of amphot ...... asive pulmonary aspergillosis.
@en
type
label
Comparative analysis of amphot ...... asive pulmonary aspergillosis.
@ast
Comparative analysis of amphot ...... asive pulmonary aspergillosis.
@en
prefLabel
Comparative analysis of amphot ...... asive pulmonary aspergillosis.
@ast
Comparative analysis of amphot ...... asive pulmonary aspergillosis.
@en
P2093
P2860
P356
P1476
Comparative analysis of amphot ...... vasive pulmonary aspergillosis
@en
P2093
Dimitrios P Kontoyiannis
Georgios Chamilos
Guangling Liao
Jinggou Hou
Randall A Prince
P2860
P304
P356
10.1128/AAC.01449-06
P407
P577
2007-01-29T00:00:00Z